Improvement of carboplatin chemosensitivity in lung cancer cells by siRNA-mediated downregulation of DLGAP1-AS2 expression
Abstract Despite being one of the primary and most effective treatments for advanced stages of lung cancer, chemotherapy drugs like carboplatin have limitations due to their adverse side effects and the development of drug resistance in lung cancer cells. However, recent studies have shown promising...
Saved in:
| Main Authors: | Sania Ghobadi Alamdari, Reza Mohammadzadeh, Mohammad Amini, Souzan Najafi, Behzad Baradaran, Seyedeh Zahra Bahojb Mahdavi, Amirhossein Yari, Amir Ali Mokhtarzadeh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-87649-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
by: Avinash Pandey, et al.
Published: (2014-01-01) -
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2025-03-01) -
The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer
by: Shu Kato, et al.
Published: (2025-04-01) -
L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release
by: Seoeun Oh, et al.
Published: (2024-12-01) -
The treatment of stage A testicular seminoma by carboplatin monochemotherapy
by: Bojanić Nebojša, et al.
Published: (2009-01-01)